A 69-year-old female mental health counselor and married mother of four, recently started an investigational precision therapy cancer drug for progressive metastatic lymphoma, which had previously failed standard medical treatment. Her prognosis was poor. However, recent image evaluation after starting experimental treatment demonstrated robust response with management at the Taylor Cancer Researc…